ArriVent BioPharma, Inc.
No enriched coverage for $AVBP in the last 7 days.
No SEC Form 4 filings for $AVBP in the last 30 days.
NEWTOWN SQUARE, Pa., Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- ArriVent BioPharma, Inc. ( Company or ArriVent ) AVBP, a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S.
NEWTOWN SQUARE, Pa., Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- ArriVent BioPharma, Inc. ( Company or ArriVent ) ( Nasdaq: AVBP ) , a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S.
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday. Shares of Centene Corporation CNC fell sharply in today's pre-market trading after the health care company withdrew its guidance for 2025.
